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Abstract
Objective: The aim of this comparative double-blind, prospective, randomized, clinical trial was to evaluate two 
amoxicillin administration patterns. The first was a short prophylactic therapy and the second a long postopera-
tive regimen. 
Study Design: The study population consisted of 160 patients who underwent mandibular third molar extraction. 
Patients were randomized into two equal groups. In group 1, 2 grams of amoxicillin were administered 1 hour 
before the procedure and 1 gram 6 hours after surgery. In group 2, patients received 1 gram of amoxicillin 6 hours 
after surgery followed by 1 gram every 8 hour for 4 days. All patients received the same number of tablets thanks 
to the use of placebo pills. A total of 25 variables were evaluated, such as alveolitis, surgical infection, number of 
analgesic needed, subjective pain scale, post-surgical inflammation, consistency of the diet, axillary temperature 
and millimetres of mouth opening loss after the surgery. 
Results: No statistically significant post-operative differences were found within the recorded parameters between 
the groups.
Conclusions: Postoperative 4-days amoxicillin therapy is not justified.  
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Introduction
Surgical third molar removal is one of the most usual 
procedures in oral and maxillofacial surgery (1,2). It is 
considered a clean-contaminated procedure due to oral 
colonization by more than 400 aerobic and anaerobic 
species (3-5). Usual postoperative sequelae are pain, 
trismus and facial swelling. The procedure can also lead 
to complications such as alveolitis (0.5-60%), and surgi-
cal infection (1-25%) (6) which is more frequent than in 
any other teeth extraction (2).
More than 40 years ago Kay obtained a spectacular 
inflammatory and infectious events reduction with the 
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only administration of one dose of penicillin prior to 
wisdom teeth removal. Since then, antibiotic admi-
nistration is a standard practice for this purpose (1,7,8). 
However there is not a widely accepted antibiotic pro-
tocol yet. Nowadays the most usual guideline is the 
postoperative administration of oral amoxicillin for 
4-8 days, for inflammatory sequelae prevention mainly 
(9,10).  However, despite 60 years of experience with the 
use of antibiotics, its systematic use for this procedure 
remains controversial (4,6). Some authors state that the 
percentage of post- surgical infections does not increase 
without the use of antibiotics (2,11), and the opposite 
opinion has been supported by others (1).
Resistant bacterial stocks selection, secondary effects 
of the drugs (headache, allergic and digestive events 
mainly) and also the added economical cost are the dis-
advantages of antibiotic use. Amoxicillin has extended 
spectrum coverage with low toxicity and unfrequent 
and well-known secondary effects (5,10,12). Although 
specific antibiotic against anaerobic bacteria such as 
metronidazole are useful for the prevention dry-socket, 
amoxicillin is more useful avoiding of wound infection. 
Some authors showed that an only dose of antibiotic is 
useful for prevention of dry-socket but not for preven-
tion of wound infection (1). Many authors defend the 
need to obtain therapeutic levels at the beginning of 
the procedure, recommending the oral administration 
at least 1 hour before the surgery (2,9,13). The objec-
tive of this clinical trial was to compare two amoxicillin 
administration patterns. The first one is a short prophy-
lactic therapy (2 doses in 1 day) and the second is a long 
postoperative regimen (4 days). 
Materials and Methods
This is a randomized, double-blinded, controlled clini-
cal trial. Two oral amoxicillin administration patterns 
for third molar surgery are compared. The initial study 
population consisted of 160 patients in whom the ex-
traction of 1 total or partial impacted mandibular third 
molar was performed in the Department of Oral and 
Maxillofacial Surgery of A Coruña University Hospi-
tal. The basic criterion for including the patient in the 
study was a need for surgical extraction of retained or 
partially erupted lower third molar due to malposition 
or any previous infectious or pain episode. 
Exclusion criteria were: age under 18 or over 60, erupt-
ed third molar or with cavity, pericoronitis or abscess 
in the previous month, systemic infectious disease, im-
munodepression, patients on corticosteroids or citosta-
tic treatment, antibiotic administration in previous 48 
hours, history of allergy or intolerance regarding any of 
the drugs prescribed in the study, intolerance to lactose, 
antecedents of recent and/or symptomatic peptic ulcer, 
pregnancy or breast-feeding, acute oral diseases and 
difficult follow-up or carry-out the treatment.
All patients were informed about the study, and written, 
dated, informed consent was obtained from all patients 
prior to study entry. The decision could be revoked at 
any time. Patients were randomly enrolled to one of the 
two treatments. Patients in group 1 (prophylaxis regi-
men group) received 2 grams of amoxicillin 1 hour be-
fore surgery in a single dose, and a second dose of 1 
gram of amoxicillin 6 hours after surgery. Afterwards 
patients took one tablet of placebo every 8 hours for 4 
days. 
Patients in group 2 (Postoperatively regimen group) re-
ceived two tablets of placebo in a single dose 1 hour 
before surgery, followed by a second dose of 1 gram 
of amoxicillin 6 hours after and one tablet of 1 gram 
amoxicillin every 8 hours for 4 days. All patients had 
the same number of tablets due to placebo pills.
The study was designed as a double blind trial in which 
the patients were randomly assigned through a blocking 
randomization scheme to two test groups according to 
the type of antibiotic treatment (short prophylactic anti-
biotic regimen or long postoperatively regimen). One of 
the pharmacists of the hospital was responsible for the 
blindness of the trial. To ensure so, a random assignment 
code was enclosed to the pharmacist, who was responsi-
ble for providing the surgeon with a pack containing 14 
tablets for every patient. The first two pills would be ad-
ministrated 1 hour before the surgery, and these would 
contain 1 gram of amoxicillin or placebo (depending of 
the assigned group). The size, color and shape of the 
tablets were exactly the same across the two groups so 
as to preserve the blindness of the study for both the 
patient and the surgeon. Furthermore, he designed his 
own internal secret drug code which was labeled to the 
outer side of the tablet` s pack. The pharmacist kept a log 
matching each individual treatment` s composition to the 
drug code (a random alpha-numerical code) and to the 
randomization code. That way he was the only person 
able to unmask the treatment assignation for any patient 
in case a severe and/or unexpected side-effect would 
take place. The same anti-inflammatory and analgesic 
drugs completed the treatment in every patient deflaza-
cort 30 mg (Zamene®, Laboratorio Menarini, Spain) 
was used as anti-inflamatory drug (one pill every 12 
hours for 5 days) and dexketoprofen in 25 mg capsules 
(Enantyum®, Laboratorio Menarini, Spain) was used 
for pain rescue, every 8 h depending on the presence 
of pain for the necessary time (the number of analgesic 
pills during the week was recorded). Mouthwash with 
0.12% chlorhexidine (Laboratorio Lacer, Spain) every 8 
hours the first week was used as well.
At the time of surgery, the surgeon was provided with 
a set of opaque, sealed envelopes, containing each the 
drug code for one patient. Every time a patient fulfilled 
the inclusion criteria and gave informed consent, an 
envelope was opened and the patient was provided the 
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tablets pack which matched the drug number. This drug 
number was registered in the patient’s diary.
The extractions were performed under local anesthesia 
following the standard technique: 4% artricaine with 
epinefrine 1:200.000 (Ultracain®, Hoechst AG, Ger-
many). A full-thickness mucoperiosteal flap was raised. 
Bone removal and odontosection were performed as 
needed, and recorded. Closure was done with resorbable 
sutures (3-0) of Polyglactin 910 (Vicryl rapid®, Ethicon, 
US). Each procedure was timed from first incision to 
completion of last suture and recorded classifying this 
variable in 3 groups (less than 5 minutes, between 5 and 
10 and more than 10 minutes). Variables were recorded 
by the surgeon on the day of the procedure, daily by the 
patient the first week and by an observer the seventh 
postoperative day. The three of them (patient, surgeon 
and observer) were blind for the treatment group as-
signed during all the study (Table 1).
GROUP 1 (2doses) GROUP 2 (4 days therapy)
SEX
     Female 
     Male
50 (71.4%)
20 (28.6%)
47 (62.7%)
28 (37.3%)
AGE (mean) 27,9 26,5
CAUSE OF EXTRACTION
     Malposition
     Malposition+Infection
     Infection
     Malposition+Pain
     Malposition+Infection+Pain
21
23
11
10
5
21
25
20
6
3
MANDIBULAR SIDE
     Left
     Right
37 (52.9%)
33 (47.1%)
36 (48%)
39 (52%)
IMPACTION
     Included
     Semi-erupted
26 (37.1%)
44 (62.9%)
31 (41.3%)
44 (58.7%)
ANGULATION TYPE
     Mesioangular
     Distoangular
     Vertical
     Horizontal
26 (37.1%)
9 (12.9%)
19 (27.1%)
16 (22.9%)
36 (48%)
5 (6.7%)
12 (16%)
22 (29.3%)
DURATION
     <5 min
      5-10 min
     >10 min
19 (27.1%)
32 (45.7%)
19 (27%)
21 (28%)
37 (49.3%)
17 (22.7%)
OSTECTOMY 58 (79.5%) 67 (87%)
TOOTH SECTION 38 (52.1%) 43 (55.8%)
INFECTION 3 (4.3%) 4 (5.3%)
ALVEOLITIS 2 (2.9%) 0
HAEMATOMA 0 2 (2.6%)
WOUND DEHISCENCE 23 (32.9%) 23 (30.3%)
INTRAORAL INFLAMMA-
TION 
35 (50%) 30 (40%)
POST-SURGICAL MOUTH 
OPENING LOSS (MEAN IN 
MM)
8.5 8.4
HYPOESTHESIA 0 3 (4%)
DIARRHOEA 1 (1.4%) 1 (1.3%)
NAUSEA OR VOMIT 0 2 (2.6%)
EPIGASTRALGIA 1 (1.4%) 0
CUTANEOUS  RASH 0 0
Table 1. Recorded variables the day of surgery and 1 week post-operatively.
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Age, sex, cause of extraction (pain, orthodontics, mal-
position or infection), the tooth to be extracted (left, 
right) and the degree of impaction (total or parcial), po-
sition (vertical. mesioangular, distoangular, horizontal), 
maximum preoperative oral opening between incisors 
(using Therabite® scale) were noted  at the preoperative 
radiographic and clinical examination.  The technical 
characteristics were recorded after the surgery: time 
duration (less than 5 minutes, 5-10 minutes, more than 
10), bone removal and sectioning of the tooth.
After surgery, every patient was provided the antibiotic 
tablets pack, a diary form and given homogeneous in-
structions for postoperative care and on how to fill in 
each item. So the patient’s answers and judgments are 
free of knowledge about the treatment received. A daily 
registration form includes the daily registration of pain 
with a subjective pain scale ranging horizontally from 0 
to 10 (visual analogue scale –VAS-), type of diet (liquid, 
soft or normal), corporal temperature and the number of 
analgesic pills taken every day (Table 2).
All patients were then given an appointment to be 
seen 7 days post-operatively and written instructions 
to consult the hospital at any time on any day in case 
of complications. Care was also taken to ensure that 
complaints noted on a day other than that of the regular 
check-up were recorded in the file. On the seventh day, 
a blind observer who did not participate in the surgi-
cal procedure was in charge of clinical follow-up of all 
the patients. Inflammatory and infectious symptoms 
were registered: alveolar osteitis, wound infection, hae-
matoma, wound dehiscence, intraoral inflammation hy-
poesthesia of lingual or alveolar nerve and maximum 
postoperative mouth opening measured using the same 
ruler used before (Therabite®) in order to estimate the 
millimetres of mouth opening loss. Side effects such as 
nausea, vomiting, epigastralgia, abdominal discomfort, 
skin rash or headache were inquired about for the exa-
mination. Besides it was noted the possible causes if the 
patient did not complete the treatment correctly.  
Clinical criteria of infection were any of the following 1) 
presence of purulent discharge in the extraction socket 
and/or excessive swelling with fluctuation, 2) presence of 
a local abscess, 3) onset of facial or cervical cellulitis plus 
other signs suggesting infection such as pain, increased 
heat, erythema and/or fever; 4) excessive swelling with 
or without pain not related to the surgical trauma. For 
alveolar osteitis diagnosis: absence of the haematic clot 
of the orifice and presence of a putrid smell and intense 
neuralgic type pain. In the last case, a second look at the 
wound and surgical cleaning were necessary.
Numeric variables were trismus (mouth opening loss, 
calculated from preoperative and postoperative mea-
surement, considering a 5 millimetres difference as 
clinically significant), subjective pain scale, number 
of analgesic tablets needed and axillary temperature. 
All the others were categorical variables. The statis-
tical software application SPSS release 16.0 for Win-
dows was used to carry out the statistical analyses. For 
categorical variables, testing for statistical differences 
was made with the x2 test or Fisher’s exact test when 
necessary. Relative risk and 95% confidence intervals 
were calculated. For continuous variables t Student test 
for independent samples was performed. All tests were 
done from a bilateral approach. P-value of less than 0.05 
was considered statistically significant 
GROUP 1 DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7
Number of analgesic needed 
(mean) 2.19 1.96 1.77 1.44 1.21 0.99 0.71
Diet
   Liquid
   Soft
   Normal
56 (80%)
13 (18.6%)
1 (1.4%)
20 (28.6%)
45 (64.3%)
5 (7.1%)
13 (18.6%)
42 (60%)
15 (21.4%)
3 (4.3%)
44 (62.9%)
23 (32.9%)
3 (4.3%)
35 (50%)
32 (45.7%)
2 (2.9%)
27 (38.6%)
41 (58.6%)
2 ( 2.9%)
21 (30%)
47 (67.1%)
Axillary Temperature (Cº) 36.6 36.6 36.5 36.5 36.4 36.4 36.3
Subjective Pain Scale (0-10) 6.7 5.0 4.2 3.6 3.2 2.8 2.4
GROUP  2 DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7
Number of analgesic needed 
(mean) 2.16 2.13 1.76 1.35 1.00 0.85 0.69
Diet
   Liquid
   Soft
   Normal
65 (86.6%)
10 (13.4%)
0
26 (34.6%)
46 (61.4%)
3 (4%)
10( 13.3%)
49 (65.3%)
16 (21.3%)
2 (2.7%)
39 (52%)
34 (45.3%)
1 (1.3%)
35 (46.7%)
39 (52%)
1 (1.3%)
23 (30.7%)
51 (68%)
0
16 (21.3%)
59 (78.7%)
Axillary Temperature (Cº) 36.6 36.5 36.6 36.5 36.4 36.5 36
Subjective Pain Scale (0-10) 6.8 4.8 3.8 3.0 2.5 2.2 1.8
Table 2. Evaluated variables by the patient during the first week.
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Results
One hundred and sixty patients were included initially 
in this study. Fifteen patients were excluded (9.4%), 9 
in group 1 and 6 in group 2. The exclusion cause was 
absence from the follow-up examination in 11 patients, 
failure to follow the recommended treatment in 3 and 1 
did not correctly fill the registration form. Phone inter-
views showed that all patients who did not came to the 
appointment argued personal reasons and no medical 
impediment.  
A total of 145 patients were included finally in the study. 
70 were assigned to group 1 (48.3%) and 75 patients in 
group 2 (51.7%), 97 women and 48 men. Both groups 
were   homogeneous in every evaluated parameters, 
such as sex distribution (71.4% women in group 1and 
62.7% in group  2) , age (mean 27.9 +- 6.7 years  in 
group 1 and 26.5 +- 6.3 in group 2), inclusion criterion, 
preoperative mouth opening, side and degree of impac-
tion of the third molar ( 26 included and 44 semi-erup-
ted in group 1 , while 31 included and 44 semi-erupted 
in group 2), position (group 1:37.1% mesioangular, 
12.9% distoangular, 27.1% vertical, 22,9% horizontal. 
Grop 2: mesioangular 48%, distoangular 6.7%, vertical 
16%, horizontal 29.3%), duration of surgery, ostectomy 
or section of the tooth.  
Postoperative infection was present in 5 patients (3.4%), 
2 in group1 (2.9%) and 3 in group 2(4%). These were 
diagnosed by purulent discharge in surgical wound in 
2 patients and excessive painfull swelling not related to 
the surgical trauma (1 of whom needed hospital admis-
sion for intravenous antibiotic treatment). Just 2 cases of 
alveolitis were recorded, both of them in group 1 (2.9%). 
No statistical relation was found either with the treat-
ment group assigned or with surgical difficulty. There 
were 2 patients with surgical infection in the less than 
5 minutes procedure group, another 2 in the group bet-
ween 5-10 minutes and 1 in a surgical extraction longer 
than 10 minutes.
No statistically significant correlation between the treat-
ment group and inflammatory symptoms was found. 
The mean of analgesic intake was 10.27 +-6.52 in group 
1 and 9.88+-7.23 in group 2. There were no differences 
in the consistency of the diet neither the subjective pain 
scale. With regard to other variables such as haematoma 
appearance, wound dehiscence, intraoral inflammation 
(present in 50.7% in group 1 and in 40% in group 2), 
trismus (mouth opening loss mean of 8.5 mm +- 9.7 in 
group 1 and 8.4 mm +- 10,8 in group 2) or lingual or al-
veolar nerve hypoesthesia no significant differences were 
found. Side effects as diarrhoea (1 patient in each group) 
nausea or vomit (2 cases in group 2) epigastralgia (1 case 
in group1), cutaneous rash (none patient) were very rare 
and without relation with the assigned treatment. Persis-
tent bad postoperative was present in 3 patients in each 
group (4.3% in group 1 and 4% in group 2).
Discussion
In spite of the high number of wisdom teeth renoval pro-
cedures, there is no antibiotic therapy protocol widely 
accepted. Some studies connect surgical complications 
with cases with ostectomy   (3,4,6) and with duration of 
surgical procedure (3). In this study these connections 
are not found. Despite total amoxicillin dose difference 
between both groups, there are no statistical difference 
in infectious and inflammatory events. Wound infection 
and alveolitis rates are similar to other published works 
(6). Some authors support the use o an only presurgi-
cal dose of amoxicillin in cases with no ostectomy re-
quired, extended to postoperative period in cases with 
bone removal (3). Other authors recommend a single 
presurgical prophylactic dose in cases with no previous 
coronitis if ostectomy is needed, leaving without antibi-
otic coverage cases when is not necessary (2). Anyway 
we consider unnecessary the long postoperative antibi-
otic patterns, because the results in the 25 study vari-
ables are comparable to the ones obtained with short 
presurgical prophylactic patterns. The implementation 
of presurgical prophylactic doses could lead added dif-
ficulty, because cooperation of the patient is necessary. 
We agree with other authors about the advantages of 
presurgical antibiotic administration as more effective 
than postoperative patterns (1,2). In this study the re-
sults are similar despite patients in presurgical adminis-
tration group receive 4 times less antibiotic dose. 
Conclusions
Postoperative infection rate was 3,5%, with no statisti-
cally differences between groups. Inflammatory symp-
toms were similar in both antibiotic administration pat-
terns groups. This study demonstrated that postopera-
tive amoxicillin therapy is not justified because it does 
not obtain better results than the short prophylactic pat-
tern, although in group 1 each patient receives 3 grams 
of amoxicillin in comparison with 12 grams of group 2. 
Side effects of antibiotic overdoses such as selection of 
resistant bacterial straits, allergic events and economic 
overcost would be avoided. 
It is not clear yet in which patients the antibiotic therapy 
is more beneficial to prevent inflammatory and infec-
tious events after third molar surgery. More multicenter 
randomized clinical trials with high external validity 
comparing alternative antibacterial therapies are nee-
ded.  The objective should be identifying patients most 
likely to benefit from antibiotic administration.
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